BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22126708)

  • 21. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological relapse prevention in alcohol and tobacco dependence].
    Diehl A; Mann K
    Internist (Berl); 2007 Jan; 48(1):79-84, 86-8. PubMed ID: 17122900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tobacco use and illicit substance use disorders: what should we have to do?].
    Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
    Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole, alcohol and substance abuse: a review.
    Brunetti M; Di Tizio L; Dezi S; Pozzi G; Grandinetti P; Martinotti G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1346-54. PubMed ID: 23104650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of treatment for nicotine dependence on alcohol and drug treatment outcomes.
    Joseph AM; Nichol KL; Anderson H
    Addict Behav; 1993; 18(6):635-44. PubMed ID: 8178702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
    Victorri-Vigneau C; Spiers A; Caillet P; Bruneau M; Ignace-Consortium ; Challet-Bouju G; Grall-Bronnec M
    Curr Neuropharmacol; 2018; 16(10):1418-1432. PubMed ID: 28721822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
    Balfour DJ; Fagerström KO
    Pharmacol Ther; 1996; 72(1):51-81. PubMed ID: 8981571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment.
    Di Nicola M; De Risio L; Pettorruso M; Caselli G; De Crescenzo F; Swierkosz-Lenart K; Martinotti G; Camardese G; Di Giannantonio M; Janiri L
    J Affect Disord; 2014; 167():285-98. PubMed ID: 24999863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
    Grant JE; Potenza MN; Kraus SW; Petrakis IL
    J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapeutic management of co-morbid alcohol and opioid use.
    Hood LE; Leyrer-Jackson JM; Olive MF
    Expert Opin Pharmacother; 2020 May; 21(7):823-839. PubMed ID: 32103695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate in the treatment of substance-related disorders: a critical review of the literature.
    Shinn AK; Greenfield SF
    J Clin Psychiatry; 2010 May; 71(5):634-48. PubMed ID: 20361908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analytic review of psychosocial interventions for substance use disorders.
    Dutra L; Stathopoulou G; Basden SL; Leyro TM; Powers MB; Otto MW
    Am J Psychiatry; 2008 Feb; 165(2):179-87. PubMed ID: 18198270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
    Doran CM; Duszynski KM; Beilby JJ; Mattick RP
    Addict Behav; 2006 Nov; 31(11):1947-58. PubMed ID: 16503093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the quality of substance dependency treatment with pharmacotherapy.
    Boyarsky BK; McCance-Katz EF
    Subst Use Misuse; 2000; 35(12-14):2095-125. PubMed ID: 11138718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy Prescribing to Patients with Concurrent Tobacco and Alcohol Use Disorder in a Large, Urban, Integrated Health System.
    Kladney M; Joudrey P; Cunningham CO; Bachhuber MA
    J Gen Intern Med; 2019 Jun; 34(6):804-805. PubMed ID: 30604121
    [No Abstract]   [Full Text] [Related]  

  • 37. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.
    Oliva EM; Maisel NC; Gordon AJ; Harris AH
    Curr Psychiatry Rep; 2011 Oct; 13(5):374-81. PubMed ID: 21773951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological gambling among cocaine-dependent outpatients.
    Hall GW; Carriero NJ; Takushi RY; Montoya ID; Preston KL; Gorelick DA
    Am J Psychiatry; 2000 Jul; 157(7):1127-33. PubMed ID: 10873922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for pregnant women with addictions.
    Rayburn WF; Bogenschutz MP
    Am J Obstet Gynecol; 2004 Dec; 191(6):1885-97. PubMed ID: 15592269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid antagonists for the treatment of alcohol dependence.
    Yancey JR; Lumbad J
    Am Fam Physician; 2011 Nov; 84(9):990-2. PubMed ID: 22046937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.